end of the downside- back in, page-79

Phase 2 aren't cheap ..

and if is a p2 + p3 assume will be more.. plus there's this pre clinical research that has been requested by fda that will take a year to gather.. ( and knowing alterity, probably a further year to collate data prior to being able to get in front of fda again to proceed to p2)

life bio was originally supposed to be taking another stake before Christmas last year ( I think around 30m ) to fujd trials but they didn't take it up.

so management has announced they are seeking funding other ways including these more regular cash raisings .


management also draws down sizable annual incomes , a long term frustration of mine.. check out the annual salary of Geoff Kempler